Company profile for Histogen

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Histogen is a regenerative medicine company focused on developing patented, innovative technologies for aesthetic and therapeutic markets that replace and regenerate tissues in the body. The Company currently has three product candidates addressing underserved, multi-billion dollar global markets: a dermal filler, a treatment for hair loss, and a treatment for joint cartilage repair. Histogen, Inc., a Delaware Corporation, was...
Histogen is a regenerative medicine company focused on developing patented, innovative technologies for aesthetic and therapeutic markets that replace and regenerate tissues in the body. The Company currently has three product candidates addressing underserved, multi-billion dollar global markets: a dermal filler, a treatment for hair loss, and a treatment for joint cartilage repair. Histogen, Inc., a Delaware Corporation, was founded in 2007 to develop innovative products utilizing the proteins and growth factors produced by cells grown under simulated embryonic conditions. The Company is headquartered in San Diego, California.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
10655 SORRENTO VALLEY ROAD, SAN DIEGO, CA 92121
Telephone
Telephone
858.526.3100
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/04/18/2865878/0/en/Histogen-Files-for-Voluntary-Chapter-11-Protection-to-Facilitate-Wind-Down-Maximize-Share-Offering.html

GLOBENEWSWIRE
18 Apr 2024

https://www.globenewswire.com//news-release/2023/12/14/2796714/0/en/Histogen-Announces-Second-Adjournment-of-Special-Meeting-of-Stockholders.html

GLOBENEWSWIRE
14 Dec 2023

https://www.globenewswire.com/news-release/2023/12/05/2791342/0/en/Histogen-Announces-Adjournment-of-Special-Meeting-of-Stockholders.html

GLOBENEWSWIRE
05 Dec 2023
Histogen winds down after search for solutions comes up short
Histogen winds down after search for solutions comes up short

19 Sep 2023

// James Waldron FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/histogen-consigned-history-biotech-winds-down-after-search-strategic-solutions-comes-short

James Waldron FIERCE BIOTECH
19 Sep 2023

https://www.globenewswire.com//news-release/2023/09/18/2745181/0/en/Histogen-Announces-Board-Approval-of-Complete-Liquidation-and-Dissolution.html

GLOBENEWSWIRE
18 Sep 2023
Histogen halts last remaining programs to conserve cash
Histogen halts last remaining programs to conserve cash

06 Jul 2023

// James Waldron FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/histogen-could-be-history-biotech-halts-all-programs-conserve-remaining-cash

James Waldron FIERCE BIOTECH
06 Jul 2023

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty